| scholarly article | Q13442814 |
| P50 | author | Aaron P. Milstone | Q115122620 |
| Todd W. Rice | Q52683245 | ||
| P2093 | author name string | Harold R Collard | |
| Beth A Malow | |||
| James E Loyd | |||
| Lisa H Lancaster | |||
| Wendi R Mason | |||
| James A Parnell | |||
| P2860 | cites work | Obstructive sleep apnea | Q70812476 |
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| [Assessment of sleep with polysomnography in patients with interstitial lung disease] | Q79138740 | ||
| Echocardiographic determination of mean pulmonary artery pressure | Q79322783 | ||
| Obstructive sleep apnea and cardiovascular disease | Q80429963 | ||
| A clinical sign to predict difficult tracheal intubation: a prospective study | Q28235648 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force | Q29615535 | ||
| Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 | ||
| General considerations for lung function testing. | Q34430848 | ||
| Prevalence of symptoms and risk of sleep apnea in the US population: Results from the national sleep foundation sleep in America 2005 poll | Q34570731 | ||
| The role of gastroesophageal reflux in idiopathic pulmonary fibrosis | Q35203065 | ||
| A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis | Q35534550 | ||
| Sleep apnea is a manifestation of the metabolic syndrome | Q36127164 | ||
| Ventilation and gas exchange during sleep in patients with interstitial lung disease | Q36159719 | ||
| Oxygen desaturation during sleep and exercise in patients with interstitial lung disease | Q36166777 | ||
| Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease | Q37077172 | ||
| Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea | Q37282714 | ||
| Study of oxygen saturation, breathing pattern and arrhythmias in patients of interstitial lung disease during sleep. | Q43601012 | ||
| Breathing during sleep in patients with interstitial lung disease | Q44738805 | ||
| Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. | Q45281655 | ||
| Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea | Q47203231 | ||
| Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis | Q48429218 | ||
| Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis | Q48471763 | ||
| Tracheal traction effects on upper airway patency in rabbits: the role of tissue pressure. | Q48475872 | ||
| The impact of continuous positive airway pressure on the lower esophageal sphincter | Q48480019 | ||
| Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) is a useful screening instrument for obstructive sleep apnea in a disease-specific population | Q48611728 | ||
| Obstructive sleep apnea and gastroesophageal reflux | Q48727981 | ||
| Sleepiness in different situations measured by the Epworth Sleepiness Scale. | Q48830273 | ||
| The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. | Q48849700 | ||
| Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale | Q48877608 | ||
| Increasing the functional residual capacity may reverse obstructive sleep apnea. | Q48955230 | ||
| Studies of oxygenation during sleep in patients with interstitial lung disease | Q49088535 | ||
| Reliability and factor analysis of the Epworth Sleepiness Scale | Q68036876 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| obstructive sleep apnea | Q16606552 | ||
| P304 | page(s) | 772-778 | |
| P577 | publication date | 2009-06-30 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Obstructive sleep apnea is common in idiopathic pulmonary fibrosis | |
| P478 | volume | 136 |
| Q28308246 | An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management |
| Q30412203 | Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials |
| Q34130706 | Association of obstructive sleep apnea risk with asthma control in adults |
| Q55016169 | Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis. |
| Q37332079 | Asthma Control and Its Relationship with Obstructive Sleep Apnea (OSA) in Older Adults |
| Q46697298 | CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? |
| Q48322004 | CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas |
| Q46106904 | Can a Floppy Upper Airway Lead to Stiff Lungs? |
| Q36860423 | Can we predict the survival of idiopathic pulmonary fibrosis patients? Sleep must be re-appreciated |
| Q34399113 | Cardiac structural and functional changes in old elderly patients with obstructive sleep apnoea-hypopnoea syndrome |
| Q33816014 | Chronic cough and obstructive sleep apnea in a community-based pulmonary practice |
| Q47736357 | Chronic intermittent hypoxia worsens bleomycin-induced lung fibrosis in rats |
| Q43856688 | Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al. |
| Q38616538 | Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management |
| Q90452494 | Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis |
| Q90291712 | Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us? |
| Q38978203 | Comprehensive Care of the Lung Transplant Patient |
| Q36707781 | Cough, sarcoidosis and idiopathic pulmonary fibrosis: raw nerves and bad vibrations |
| Q38288028 | Diagnosis and management of interstitial lung disease |
| Q89566561 | Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden |
| Q99634847 | Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review |
| Q45955311 | Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. |
| Q44615427 | How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? |
| Q34634746 | Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases |
| Q38793193 | Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review. |
| Q56764887 | Idiopathic pulmonary fibrosis |
| Q87721963 | Idiopathic pulmonary fibrosis |
| Q38205617 | Idiopathic pulmonary fibrosis: early detection and referral |
| Q38947435 | Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities |
| Q38826634 | Immune Mechanisms in Pulmonary Fibrosis |
| Q36739149 | Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis |
| Q57071456 | Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives |
| Q41116646 | Increased hemoglobin-oxygen affinity ameliorates bleomycin-induced hypoxemia and pulmonary fibrosis |
| Q38461691 | Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea |
| Q55425888 | Intermittent Hypoxia Increases the Severity of Bleomycin-Induced Lung Injury in Mice. |
| Q85213941 | Interstitial lung disease: new challenges and evolving phenotypes |
| Q48247097 | Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis? |
| Q58774992 | Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis |
| Q92155008 | Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights |
| Q26766526 | Management of interstitial lung disease associated with connective tissue disease |
| Q26785617 | Managing comorbidities in idiopathic pulmonary fibrosis |
| Q37888661 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis |
| Q26765586 | New perspectives on management of idiopathic pulmonary fibrosis |
| Q34432217 | New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses |
| Q40160441 | Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in MESA. |
| Q35993864 | Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease. |
| Q36898797 | Obstructive sleep apnea in patients with end-stage lung disease |
| Q46001904 | Obstructive sleep apnea in patients with interstitial lung diseases: past and future. |
| Q48184834 | Obstructive sleep apnea is common in patients with interstitial lung disease |
| Q48070754 | Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis |
| Q43416986 | Obstructive sleep apnea syndrome: complaints and housing characteristics in a population in the United States |
| Q93165492 | Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment |
| Q90207282 | Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns |
| Q50217261 | Pharmakologische und nicht-pharmakologische Therapie der idiopathischen Lungenfibrose |
| Q34574174 | Pirfenidone treatment of idiopathic pulmonary fibrosis. |
| Q36352207 | Pulmonary Overlap Syndromes, with a focus on COPD and ILD. |
| Q40272697 | Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis |
| Q64066557 | Relation of Warrick Score and Polysomnographic Parameters in Patients with Interstitial Lung Disease |
| Q51169568 | Relationship between parenchymal involvement and obstructive sleep apnea in subjects with sarcoidosis. |
| Q90537703 | Risk factors for the development of idiopathic pulmonary fibrosis: A review |
| Q38291561 | Sleep disordered breathing in interstitial lung disease: A review |
| Q47672952 | Sleep disorders and health-related quality of life in patients with interstitial lung disease |
| Q36860416 | Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis |
| Q41070023 | Sleep-disordered breathing and idiopathic pulmonary fibrosis--is there an association? |
| Q54969923 | Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review. |
| Q44800059 | The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet |
| Q39414945 | The overlaps of asthma or COPD with OSA: A focused review |
| Q91868153 | The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis |
| Q26741569 | Therapeutic Approach to Adult Fibrotic Lung Diseases |
| Q37827436 | Therapeutic update in idiopathic pulmonary fibrosis |
| Q47791471 | Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia |
| Q26781255 | Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review |
| Q89287564 | Understanding Pathophysiological Concepts Leading to Obstructive Apnea |
| Q28083702 | Update on diagnosis and treatment of idiopathic pulmonary fibrosis |
| Q28603445 | Workshop on idiopathic pulmonary fibrosis in older adults |
Search more.